Results by Cambridge-based Intellia and Regeneron show how CRISPR could transform treatment

In a milestone for gene therapy, drugmakers Intellia Therapeutics and Regeneron Pharmaceuticals reported results from the first clinical trial using Nobel Prize-winning CRISPR technology to treat disease inside the human body.